Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Spruce Biosciences (SPRB)
NASDAQ:SPRB
RESEARCH TOOLSreports
Spruce Biosciences (SPRB) Stock Price & Analysis
176 Followers
SPRB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.95 - $3.57
Previous Close$1.58
Volume135.73K
Average Volume (3M)76.71K
Market Cap
$64.32M
Enterprise Value-$52.07M
Total Cash (Recent Filing)$120.52M
Total Debt (Recent Filing)$4.13M
Price to Earnings (P/E)-0.9
Beta1.11
Next Earnings
Nov 22, 2023EPS Estimate
-$0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.67
Shares Outstanding40,710,692
10 Day Avg. Volume90,642
30 Day Avg. Volume76,708
Standard Deviation0.37
R-Squared0.08
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.67
Price to Sales (P/S)29.24
Price to Cash Flow (P/CF)8.10
P/FCF Ratio7.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-12.40
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda1.05
Forecast
1Y Price Target
$8.40Price Target Upside510.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Spruce Biosciences News
Stock Analysis & Ideas2 “Strong Buy” Penny Stocks With Multibagger Potential
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SPRB FAQ
What was Spruce Biosciences’s price range in the past 12 months?
Spruce Biosciences lowest stock price was $0.95 and its highest was $3.57 in the past 12 months.
What is Spruce Biosciences’s market cap?
Currently, no data Available
When is Spruce Biosciences’s upcoming earnings report date?
Spruce Biosciences’s upcoming earnings report date is Nov 22, 2023 which is in 34 days.
How were Spruce Biosciences’s earnings last quarter?
Spruce Biosciences released its earnings results on Aug 14, 2023. The company reported -$0.32 earnings per share for the quarter, beating the consensus estimate of -$0.392 by $0.072.
Is Spruce Biosciences overvalued?
According to Wall Street analysts Spruce Biosciences’s price is currently Undervalued.
Does Spruce Biosciences pay dividends?
Spruce Biosciences does not currently pay dividends.
What is Spruce Biosciences’s EPS estimate?
Spruce Biosciences’s EPS estimate is -$0.35.
How many shares outstanding does Spruce Biosciences have?
Spruce Biosciences has 40,710,693 shares outstanding.
What happened to Spruce Biosciences’s price movement after its last earnings report?
Spruce Biosciences reported an EPS of -$0.32 in its last earnings report, beating expectations of -$0.392. Following the earnings report the stock price went down -1.37%.
Which hedge fund is a major shareholder of Spruce Biosciences?
Among the largest hedge funds holding Spruce Biosciences’s share is Omega Fund Management, LLC. It holds Spruce Biosciences’s shares valued at 5M.
---
Spruce Biosciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8.40 (510.91% Upside)
$8.40 (510.91% Upside)
Blogger Sentiment
Bullish
SPRB Sentiment 100%
Sector Average 69%
Sector Average 69%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 2.7%
Last 30 Days ▼ 2.7%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
31.66%
12-Months-Change
Fundamentals
Return on Equity
-51.87%
Trailing 12-Months
Asset Growth
20.52%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Spruce Biosciences
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
---
Top 5 ETFs holding SPRB
Vanguard Total Stock Market ETF
$331.22K
Dimensional US Core Equity 1 ETF
$19.44
Up to five ETFs with an Outperform Smart Score that hold SPRB. The ETFs are listed according to market value of SPRB within the ETF
Sangamo Biosciences
―
Sutro Biopharma
―
Fate Therapeutics
―
Ultragenyx Pharmaceutical
―
---